Ascletis
Sagimet announces positive results for Ascletis’ denifanstat in moderate to severe acne
Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment
Chinese biotechs aim PD-L1 antibody at hepatitis B
Cancer therapies could help boost patient's immune system
Dermira craters as acne drug fails late-stage test
The US biotech lost two-thirds of its share value after the news broke
France ignores EMA and suspends Bayer’s Diane 35
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
EMA says Bayer’s Diane 35 should remain on European market
Agency investigation concludes acne treatment's benefits outweigh its risks
Roche taps local expertise for hep C drug in China
Partners with Chinese-American biotech company Ascletis
